Safety and cardiovascular effects of multiple‐dose administration of aripiprazole and olanzapine in a randomised clinical trial - Koller - 2021 - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library

Pharmacokinetics, tolerability and safety of aripiprazole once-monthly in adult schizophrenia: An open-label, parallel-arm, multiple-dose study

Synthesis and Characterization of 5-(2-Fluoro-4-[11C]methoxyphenyl)-2,2-dimethyl-3,4-dihydro-2H-pyrano[2,3-b]pyridine-7-carboxamide as a PET Imaging Ligand for Metabotropic Glutamate Receptor 2

Antipsychotic - Wikipedia

Prevention and treatment of traumatic brain injury-related delirium: a systematic review

(PDF) Important pharmacogenetic information for drugs prescribed during the SARS-CoV-2 infection (COVID-19)

Recent advances in dopamine D2 receptor ligands in the treatment of neuropsychiatric disorders - Juza - 2023 - Medicinal Research Reviews - Wiley Online Library

Antipsychotic - Wikipedia

The impact of adjunctive aripiprazole on QT interval: A 12‐week open label study in patients on olanzapine, clozapine or risperidone - Pilunthanakul - 2023 - Human Psychopharmacology: Clinical and Experimental - Wiley Online Library

PDF) The impact of adjunctive aripiprazole on QT interval: A 12-week open label study in patients on olanzapine, clozapine or risperidone

A Randomized, Open-Label, Multiple-Dose, Parallel-Arm, Pivotal Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Aripiprazole 2-Month Long-Acting Injectable in Adults With Schizophrenia or Bipolar I Disorder